How nELISA miniaturizes immunoassays on beads, overcoming reagent-driven cross-reactivity and reducing costs.

BioRxiv ; We present the nELISA, a miniaturised, high-throughput, and high-fidelity protein profiling platform.

True Multiplexing Unlocks Scalable Proteomics

High-throughput protein profiling technology enables comprehensive and quantitative mapping of cytokine interactions

Project will quantify circulating protein markers in ~3000 patient blood samples from PICI’s RADIOHEAD study using Nomic’s nELISA™ high-throughput protein profiling platform to better understand how patients respond to treatment

Nomic is closing of an oversubscribed US$17 million Series A funding round, bringing the company's total funding to date to over US$21 million.

Hewett brings invaluable operational and strategic expertise to guide Nomic Bio through its crucial years of growth.

Nomic’s nELISA will be used to profile 200 secreted proteins for ten thousand samples to provide consortium partners complementary information about the secretome

Accessing our profiling service is a simple and seamless experience. We offer comprehensive, end-to-end support to help you harness the power of the proteome.

The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.

Enabling well-powered studies, absolute quantification, and unlimited content flexibility